The approval of perpetual futures contracts in the US may expose traders to unforeseen tax and regulatory risks, according to CME Group Chairman and CEO Terry Duffy, due to the ambiguity surrounding their classification as either swaps or futures. This issue has sparked a legal battle between CME and the Commodity Futures Trading Commission (CFTC), with the outcome potentially influencing the US approach to perpetual futures.
The core of the dispute lies in whether perpetual futures should be legally considered swaps or futures, which significantly affects their tax treatment. Duffy argues that perpetual contracts, which involve periodic funding payments, align more closely with the definition of swaps under US law.
If classified as swaps, these contracts would be subject to ordinary taxation, rather than the blended tax treatment available for futures under Section 1256 of the US tax code. This discrepancy could lead to uncertainty for institutional traders in reporting their positions to the IRS, especially if the contracts are ultimately deemed to be swaps. Legal experts view the issue as complex, with the definition of swaps being broad and open to interpretation.
The resolution of this matter may require court interpretation, potentially leading to a lengthy litigation process. Ultimately, the classification of perpetual futures could have significant implications for market participants, regulators, and tax authorities, highlighting the need for clarity on their tax treatment.